FdaApplication
BLA 761274
Identifiers
- fda_app_no: BLA761274
Properties
| Property | Value |
|---|---|
| applicant_name | Biocon Biologics Inc. |
| application_type | BLA |
| approval_date | 2024-05-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| YESAFILI | AFLIBERCEPT-JBVF | 2MG/0.05ML | Injection |
| YESAFILI | — | 2MG/0.05ML | Injection |
2 products